Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.

Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.

Item
http://www.wikidata.org/entity/Q34658632
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsEfavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsDevelopment of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutationsEfavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individualsMolecular epidemiology of HIV in two highly endemic areas of northeastern South Africa.Atazanavir signature I50L resistance substitution accounts for unique phenotype of increased susceptibility to other protease inhibitors in a variety of human immunodeficiency virus type 1 genetic backbonesEfavirenz for HIV-1 infection in adults: an overview.Comparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settingsSaquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.Efavirenz: a review.Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon.Moving forward with treatment options for HIV-infected children.Replacement of protease inhibitors by nevirapine or efavirenz in simplification and rescue interventions: which works better?Practical Bayesian design and analysis for drug and device clinical trials.Incidence of neuropsychiatric side effects of efavirenz in HIV-positive treatment-naïve patients in public-sector clinics in the Eastern Cape.
P2860

Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.

Item
http://www.wikidata.org/entity/Q34658632
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@ast
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@en
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@nl
type
label
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@ast
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@en
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@nl
prefLabel
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@ast
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@en
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Genetic mechanisms of resistance to protease inhibitors and entry inhibitors.
@en
P2093
P304
P31
P356
10.1310/0CJ5-2ABQ-CB00-6MR6
P433
P478
P50
P577
P698